Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43 |
Resumo: | Pediatric obesity is an important public health problem nowadays. Portugal is no exception, being one third of children and adolescent either overweight or obese. The behavioral approach is the basilar stone of obese treatment nowadays. It focuses in change lifestyle, substituting unhealthy habits by new, healthier, ones.A great number of strategies have been studied to try to respond to this growing problem, with varying results. The heterogeneity present in the scientific literature is likely to be explained by different study designs and targeted populations. Nevertheless, the results, in general, support that improvements in diet and increase in physical exercise pattern are associated with improvements in risk factors for cardiovascular disease, namely an atherogenic lipid profile, insulin resistance and inflammation, besides the reduction in adiposity itself.The combination of diet and exercise in the same intervention appear to be beneficial and complementary. However, different types of diet and exercise might lead to different results.The use of pharmacological adjuvants in pediatric obesity treatment is very limited in clinical practice due, mainly, to the lack of adequate studies; however some options have demonstrated to contribute to a small, but consistent, improvement in adiposity. Surgery, on the other hand, is the last therapeutic option and should be considered only in the more severe cases.Pediatric obesity tends to track until adulthood, and is associated with increased risk of cardiovascular disease in the future. Acting as early as possible in an individual life, when health habits are easier to acquire, and likelier to be kept, is crucial.Governments, including the Portuguese, have been paying more attention to this issue in the last years. However, much more can be made in general policies to create a less obesogenic environment and make the healthy choices the easier ones. |
id |
RCAP_af1426ff8f5a9e3c7b56ff3fe78f3136 |
---|---|
oai_identifier_str |
oai:ojs.actafarmaceuticaportuguesa.com:article/43 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markersEstratégias terapêuticas para a obesidade pediátrica e sua influência nos marcadores de risco cardiovascularPediatric obesityinterventioncardiovascular diseaseObesidade pediátricaintervençãodoença cardiovascularPediatric obesity is an important public health problem nowadays. Portugal is no exception, being one third of children and adolescent either overweight or obese. The behavioral approach is the basilar stone of obese treatment nowadays. It focuses in change lifestyle, substituting unhealthy habits by new, healthier, ones.A great number of strategies have been studied to try to respond to this growing problem, with varying results. The heterogeneity present in the scientific literature is likely to be explained by different study designs and targeted populations. Nevertheless, the results, in general, support that improvements in diet and increase in physical exercise pattern are associated with improvements in risk factors for cardiovascular disease, namely an atherogenic lipid profile, insulin resistance and inflammation, besides the reduction in adiposity itself.The combination of diet and exercise in the same intervention appear to be beneficial and complementary. However, different types of diet and exercise might lead to different results.The use of pharmacological adjuvants in pediatric obesity treatment is very limited in clinical practice due, mainly, to the lack of adequate studies; however some options have demonstrated to contribute to a small, but consistent, improvement in adiposity. Surgery, on the other hand, is the last therapeutic option and should be considered only in the more severe cases.Pediatric obesity tends to track until adulthood, and is associated with increased risk of cardiovascular disease in the future. Acting as early as possible in an individual life, when health habits are easier to acquire, and likelier to be kept, is crucial.Governments, including the Portuguese, have been paying more attention to this issue in the last years. However, much more can be made in general policies to create a less obesogenic environment and make the healthy choices the easier ones.A obesidade pediátrica é actualmente um problema de saúde pública crescente. Portugal não é excepção sendo que um terço da população pediátrica e adolescente apresenta excesso de peso ou mesmo obesidade. A abordagem comportamental é a pedra basilar dos tratamentos da obesidade, focando-se em alterações do estilo de vida e substituição de hábitos nefastos por outros saudáveis.Um elevado número de estratégias foram estudadas para responder a este problema crescente apresentando, contudo, resultados variáveis. A heterogeneidade de resultados apresentada na literatura cientifica pode ser explicada por diferentes desenhos de estudo e de populações alvo. Não obstante, os resultados apontam no sentido de que melhorias na dieta e no padrão de actividade fisica estão associados com melhorias no factor de risco cardiovascular, nomeadamente do perfil aterogénico lipidico, resistência à insulina, inflamação, para além da redução da própria adiposidade.A combinação de dieta e exercício na mesma intervenção parece ser benéfica e complementar. No entanto, diferentes tipos de actividade fisica e de dieta podem levar a resultados diferentes. O uso de adjuvantes farmacológicos no tratamento da obesidade pediátrica é altamente limitado na prática clinica, especialmente devido à falta de estudos adequeados; contudo algumas opções demonstraram contribuir para uma pequena mas consistente melhoria da adiposidade. A cirurgia é uma solução de ultimo recurso e para casos extremos.A obesidade pediátrica tende a manter-se até à idade adulta e está associada a um aumento do risco cardiovascular futuro. Uma actuação tão precoce quanto possível, quando é mais fácil a aquisição de habitos adequados, é crucialOs governos estão a prestar cada vez mais atenção a este assunto. Contudo, muito mais pode ser feito em termos de politicas globais, no sentido de criar um ambiente menos propicio à obesidade e favorável à escolha de opções mais saudáveis.Acta Farmacêutica Portuguesa2014-07-01T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43oai:ojs.actafarmaceuticaportuguesa.com:article/43Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 79-922182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPengporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43/49https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43/82Nascimento, H.Quintanilha, A.Santos-Silva, A.Belo, L.info:eu-repo/semantics/openAccess2022-09-05T12:29:45Zoai:ojs.actafarmaceuticaportuguesa.com:article/43Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:59:53.931510Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers Estratégias terapêuticas para a obesidade pediátrica e sua influência nos marcadores de risco cardiovascular |
title |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
spellingShingle |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers Nascimento, H. Pediatric obesity intervention cardiovascular disease Obesidade pediátrica intervenção doença cardiovascular |
title_short |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
title_full |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
title_fullStr |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
title_full_unstemmed |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
title_sort |
Therapeutic strategies for pediatric obesity and their effect in cardiovascular disease risk markers |
author |
Nascimento, H. |
author_facet |
Nascimento, H. Quintanilha, A. Santos-Silva, A. Belo, L. |
author_role |
author |
author2 |
Quintanilha, A. Santos-Silva, A. Belo, L. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Nascimento, H. Quintanilha, A. Santos-Silva, A. Belo, L. |
dc.subject.por.fl_str_mv |
Pediatric obesity intervention cardiovascular disease Obesidade pediátrica intervenção doença cardiovascular |
topic |
Pediatric obesity intervention cardiovascular disease Obesidade pediátrica intervenção doença cardiovascular |
description |
Pediatric obesity is an important public health problem nowadays. Portugal is no exception, being one third of children and adolescent either overweight or obese. The behavioral approach is the basilar stone of obese treatment nowadays. It focuses in change lifestyle, substituting unhealthy habits by new, healthier, ones.A great number of strategies have been studied to try to respond to this growing problem, with varying results. The heterogeneity present in the scientific literature is likely to be explained by different study designs and targeted populations. Nevertheless, the results, in general, support that improvements in diet and increase in physical exercise pattern are associated with improvements in risk factors for cardiovascular disease, namely an atherogenic lipid profile, insulin resistance and inflammation, besides the reduction in adiposity itself.The combination of diet and exercise in the same intervention appear to be beneficial and complementary. However, different types of diet and exercise might lead to different results.The use of pharmacological adjuvants in pediatric obesity treatment is very limited in clinical practice due, mainly, to the lack of adequate studies; however some options have demonstrated to contribute to a small, but consistent, improvement in adiposity. Surgery, on the other hand, is the last therapeutic option and should be considered only in the more severe cases.Pediatric obesity tends to track until adulthood, and is associated with increased risk of cardiovascular disease in the future. Acting as early as possible in an individual life, when health habits are easier to acquire, and likelier to be kept, is crucial.Governments, including the Portuguese, have been paying more attention to this issue in the last years. However, much more can be made in general policies to create a less obesogenic environment and make the healthy choices the easier ones. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-07-01T00:00:00Z |
dc.type.driver.fl_str_mv |
journal article info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43 oai:ojs.actafarmaceuticaportuguesa.com:article/43 |
url |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43 |
identifier_str_mv |
oai:ojs.actafarmaceuticaportuguesa.com:article/43 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43 https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43/49 https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/43/82 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
dc.source.none.fl_str_mv |
Acta Farmacêutica Portuguesa; v. 3 n. 1 (2014); 79-92 2182-3340 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799129871023079424 |